Literature DB >> 22371475

Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels.

Swetha S Murali1, Ian A Napier, Beth K Rycroft, MacDonald J Christie.   

Abstract

The opioid-related receptor, ORL1, is activated by the neuropeptide nociceptin/orphanin FQ (N/OFQ) and inhibits high-voltage-activated (HVA) calcium channel currents (I(Ca)) via a G-protein-coupled mechanism. Endocytosis of ORL1 receptor during prolonged N/OFQ exposure was proposed to cause N-type voltage-gated calcium channel (VGCC) internalization via physical interaction between ORL1 and the N-type channel. However, there is no direct electrophysiological evidence for this mechanism in dorsal root ganglion (DRG) neurons or their central nerve terminals. The present study tested this using whole-cell patch-clamp recordings of HVA I(Ca) in rat DRG neurons and primary afferent excitatory synaptic currents (eEPSCs) in spinal cord slices. DRG neurons were classified on the basis of diameter, isolectin-B4 (IB4) binding and responses to capsaicin, N/OFQ and a μ-opioid agonist, DAMGO. IB4-negative neurons less than 20 μm diameter were selectively responsive to N/OFQ as well as DAMGO. In these neurons, ORL1 desensitization by a supramaximal concentration of N/OFQ was not followed by a decrease in HVA I(Ca) current density or proportion of whole-cell HVA I(Ca) contributed by N-type VGCC as determined using the N-type channel selective blocker, ω-conotoxin CVID. There was also no decrease in the proportion of N-type I(Ca) when neurons were incubated at 37°C with N/OFQ for 30 min prior to recording. In spinal cord slices, N/OFQ consistently inhibited eEPSCs onto dorsal horn neurons. As observed in DRG neurons, preincubation of slices in N/OFQ for 30 min produced no decrease in the proportion of eEPSCs inhibited by CVID. In conclusion, no internalization of the N-type VGCC occurs in either the soma or central nerve terminals of DRG neurons following prolonged exposure to high, desensitizing concentrations of N/OFQ.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22371475      PMCID: PMC3413501          DOI: 10.1113/jphysiol.2012.228429

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  44 in total

1.  Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes.

Authors:  R J Lewis; K J Nielsen; D J Craik; M L Loughnan; D A Adams; I A Sharpe; T Luchian; D J Adams; T Bond; L Thomas; A Jones; J L Matheson; R Drinkwater; P R Andrews; P F Alewood
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

2.  Binding sites for the plant lectin Bandeiraea simplicifolia I-isolectin B(4) are expressed by nociceptive primary sensory neurones.

Authors:  M B Gerke; M B Plenderleith
Journal:  Brain Res       Date:  2001-08-17       Impact factor: 3.252

3.  Nociceptin is a potent inhibitor of N-type Ca(2+) channels in rat sympathetic ganglion neurons.

Authors:  K P Larsson; U B Olsen; A J Hansen
Journal:  Neurosci Lett       Date:  2000-12-22       Impact factor: 3.046

4.  Nociceptin-induced internalization of the ORL1 receptor in human neuroblastoma cells.

Authors:  S Spampinato; R Di Toro; A R Qasem
Journal:  Neuroreport       Date:  2001-10-08       Impact factor: 1.837

5.  Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse.

Authors:  S L Borgland; M Connor; M J Christie
Journal:  J Physiol       Date:  2001-10-01       Impact factor: 5.182

6.  ORL1 receptor-mediated internalization of N-type calcium channels.

Authors:  Christophe Altier; Houman Khosravani; Rhian M Evans; Shahid Hameed; Jean B Peloquin; Brian A Vartian; Lina Chen; Aaron M Beedle; Stephen S G Ferguson; Alexandre Mezghrani; Stefan J Dubel; Emmanuel Bourinet; John E McRory; Gerald W Zamponi
Journal:  Nat Neurosci       Date:  2005-11-27       Impact factor: 24.884

7.  Expression of orphanin FQ/nociceptin and its receptor in rat peripheral ganglia and spinal cord.

Authors:  Lina M E Pettersson; Frank Sundler; Nils Danielsen
Journal:  Brain Res       Date:  2002-08-02       Impact factor: 3.252

8.  Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?

Authors:  Hanns Ulrich Zeilhofer; Girolamo Calò
Journal:  J Pharmacol Exp Ther       Date:  2003-04-29       Impact factor: 4.030

9.  Agonist-induced internalization and desensitization of the human nociceptin receptor expressed in CHO cells.

Authors:  S Spampinato; R Di Toro; M Alessandri; G Murari
Journal:  Cell Mol Life Sci       Date:  2002-12       Impact factor: 9.261

10.  Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.

Authors:  R K Reinscheid; H P Nothacker; A Bourson; A Ardati; R A Henningsen; J R Bunzow; D K Grandy; H Langen; F J Monsma; O Civelli
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

View more
  14 in total

1.  Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation.

Authors:  Meng-Hua Zhou; Alexis Bavencoffe; Hui-Lin Pan
Journal:  J Biol Chem       Date:  2015-10-27       Impact factor: 5.157

2.  Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.

Authors:  A Jayamanne; H J Jeong; C I Schroeder; R J Lewis; M J Christie; C W Vaughan
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 3.  Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.

Authors:  W Schröder; D G Lambert; M C Ko; T Koch
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

4.  γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins.

Authors:  Hartmut Cuny; Andrew de Faoite; Thuan G Huynh; Takahiro Yasuda; Géza Berecki; David J Adams
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

Review 5.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

Review 6.  Regulation of Ca(V)2 calcium channels by G protein coupled receptors.

Authors:  Gerald W Zamponi; Kevin P M Currie
Journal:  Biochim Biophys Acta       Date:  2012-10-12

Review 7.  Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

Authors:  Courtney L Donica; Hibah O Awwad; Deepak R Thakker; Kelly M Standifer
Journal:  Mol Pharmacol       Date:  2013-02-08       Impact factor: 4.436

8.  Serine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling.

Authors:  Nancy R Zhang; William Planer; Edward R Siuda; Hu-Chen Zhao; Lucy Stickler; Steven D Chang; Madison A Baird; Yu-Qing Cao; Michael R Bruchas
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

9.  Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization.

Authors:  Akihiko Ozawa; Gloria Brunori; Daniela Mercatelli; Jinhua Wu; Andrea Cippitelli; Bende Zou; Xinmin Simon Xie; Melissa Williams; Nurulain T Zaveri; Sarah Low; Grégory Scherrer; Brigitte L Kieffer; Lawrence Toll
Journal:  J Neurosci       Date:  2015-08-19       Impact factor: 6.167

10.  Novel ω-conotoxins from C. catus reverse signs of mouse inflammatory pain after systemic administration.

Authors:  Mahsa Sadeghi; Swetha S Murali; Richard J Lewis; Paul F Alewood; Sarasa Mohammadi; MacDonald J Christie
Journal:  Mol Pain       Date:  2013-10-20       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.